Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effective dose of remimazolam combined with etomidate for general anesthesia induction (BCD method)
ChiCTR2200067177Phase 4Recruiting
- Sponsor
- The Affiliated Shunde Hospital of Jinan University
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and etomidate in None (5 arms), sponsored by The Affiliated Shunde Hospital of Jinan University. Primary endpoints: blood pressure, heart rate and 1 more. Started Jul 2022; status: recruiting.
02
Drugs
remimazolametomidate
Beyond the preview
Go deeper on ChiCTR2200067177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200067177.